News

Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational ...
Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing ...
Cancer dysregulates the complex structure of tissues and internal cellular pathways. As a result, the immune system loses its ...
Novel genetic insights into frailty highlight potential early predictors, aiding in the prevention of age-related decline and ...
Currently, GenAns Biotech is conducting investigator-initiated trials for several gene therapies, including GA001 for ...
Many major cancers, including those of the lung, breast and prostate gland, spread to the bones as they progress.
Many major cancers, including those of the lung, breast and prostate gland, spread to the bones as they progress. These bone metastases are often debilitating, even deadly. They are also notoriously ...
Cell division is an essential process by which living organisms grow, replenish lost cells, and regenerate dead and damaged ...
Precision is advancing the final U.S. investigational new drug (IND)-enabling toxicology studies with an anticipated IND and/or clinical trial application (CTA) filing targeted by the end of 2025 with ...
Q2 2025 Earnings Call Transcript August 6, 2025 Arvinas, Inc. beats earnings expectations. Reported EPS is $-0.83836, ...
Experts repeatedly emphasize that fruit does not cause inflammation. Barrie Kaiden notes that the recent study in Molecular ...